Investors Asset Management of Georgia Inc. GA ADV Sells 125 Shares of Cardinal Health, Inc. (NYSE:CAH)

Investors Asset Management of Georgia Inc. GA ADV cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,800 shares of the company’s stock after selling 125 shares during the quarter. Investors Asset Management of Georgia Inc. GA ADV’s holdings in Cardinal Health were worth $331,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. State Street Corp increased its position in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the period. Geode Capital Management LLC raised its position in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after acquiring an additional 42,082 shares in the last quarter. Pacer Advisors Inc. lifted its stake in shares of Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after purchasing an additional 191,568 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after purchasing an additional 33,388 shares in the last quarter. Finally, Two Sigma Advisers LP grew its stake in Cardinal Health by 47.9% in the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after purchasing an additional 346,362 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.5 %

Shares of CAH stock opened at $127.35 on Friday. The stock has a market capitalization of $30.76 billion, a P/E ratio of 23.76, a P/E/G ratio of 1.48 and a beta of 0.63. The firm’s 50 day moving average is $123.45 and its 200 day moving average is $116.88. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CAH. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. UBS Group lifted their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Barclays upped their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $132.00 to $145.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.